Soligenix (NASDAQ:SNGX – Get Rating) and Puma Biotechnology (NASDAQ:PBYI – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, risk, institutional ownership, earnings and analyst recommendations. Risk & Volatility Soligenix has a beta of 1.74, indicating […]